Vestibular schwannoma (VS) is a benign tumor growing from Schwann cells of the vestibulocochlear nerve (cranial nerve VIII), accounting for 6-8% of brain tumors. Cystic vestibular schwannoma (cVS) represents 10% of VS cases and is characterized by unpredictable growth and worse surgical outcomes compared to solid VS (sVS). The molecular mechanisms underlying this aggressive phenotype remain poorly understood....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — findings are exploratory molecular signatures with no immediate clinical or treatment application.
Identifying molecular differences between cystic and solid vestibular schwannomas could eventually inform prognosis prediction and targeted management strategies.
- 01Transcriptome-wide profiling compared gene expression in cystic vs. solid vestibular schwannomas.
- 02Candidate long non-coding RNA (lncRNA) signatures were identified that differentiate the two tumor subtypes.
- 03Cystic vestibular schwannomas tend to behave more aggressively clinically, making molecular differentiation valuable.
- 04Findings are preliminary and require validation in larger independent cohorts.
- 05No direct diagnostic or therapeutic tool is proposed at this stage.
Distinct long non-coding RNA signatures differentiate cystic from solid vestibular schwannomas at the transcriptome level.
studypartially supported- PMID
- 42507076
- DOI
- 10.1007/s11033-026-12429-y.
- Journal
- Molecular Biology Reports
- Publication type
- research_article
- Evidence level
- 3
- Population
- Patients with cystic and solid vestibular schwannomas undergoing surgical resection
- Intervention
- Transcriptome-wide RNA profiling including long non-coding RNAs
- Comparator
- Solid vestibular schwannomas vs. cystic vestibular schwannomas
Primary outcomes
Identification of differentially expressed long non-coding RNAs between cystic and solid vestibular schwannomas